{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T19:35:20Z","timestamp":1777836920730,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ahj.2018.06.018","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T11:09:25Z","timestamp":1535195365000},"page":"118-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs"],"prefix":"10.1016","volume":"205","author":[{"given":"Leif","family":"Friberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2018.06.018_bb0005","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"3","author":"Lafuente-Lafuente","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ahj.2018.06.018_bb0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2018.06.018_bb0015","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2018.06.018_bb0020","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.06.018_bb0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ahj.2018.06.018_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10654-009-9404-1","article-title":"Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity","volume":"25","author":"Smith","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ahj.2018.06.018_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000345953","article-title":"Refinement of Swedish administrative registers to monitor stroke events on the national level","volume":"40","author":"Koster","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ahj.2018.06.018_bb0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejheart.2004.12.007","article-title":"The validity of a diagnosis of heart failure in a hospital discharge register","volume":"7","author":"Ingelsson","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2018.06.018_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0404.2010.01402.x","article-title":"Validation of the Swedish inpatient and cause-of-death registers in the context of stroke","volume":"123","author":"Appelros","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ahj.2018.06.018_bb0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1160\/TH16-05-0400","article-title":"Usefulness of health registers for detection of bleeding events in outcome studies","volume":"116","author":"Friberg","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2018.06.018_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2012.96867","article-title":"Prespecified falsification end points: can they validate true observational associations?","volume":"309","author":"Prasad","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2018.06.018_bb0065","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.2013.3089","article-title":"Falsification end points for observational studies","volume":"309","author":"Groenwold","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2018.06.018_bb0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","journal-title":"NEJM"},{"key":"10.1016\/j.ahj.2018.06.018_bb0075","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2014.02.601","article-title":"Safety of dronedarone in routine clinical care","volume":"63","author":"Friberg","year":"2014","journal-title":"JACC"},{"key":"10.1016\/j.ahj.2018.06.018_bb0080","author":"The National Board of Health and Welfare"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:08Z","timestamp":1757570468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":15,"alternative-id":["S0002870318302539"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.06.018","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}